Delivery Order SPE2DX15D1902-SPE2DX24FC2CL
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,514.78 firm fixed price delivery order contract to provide the pharmaceutical product moxifloxacin hydrochloride. The award has a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,103.30 contract is for the delivery of the pharmaceutical product Moxifloxacin Hydrochl by the completion date of December 26, 2023. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceuticals and medical supplies to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is valued at $1,388.46 and has a completion date of January 30, 2024. It provides for the delivery of 400 mg Moxifloxacin HCL tablets to support military treatment programs and medical facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,723.59 contract is for the supply of moxifloxacin hydrochloride, a pharmaceutical product. The contract has a completion date of February 23, 2024 and was awarded on December 22, 2023. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. The contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX24FC5KQ) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of moxifloxacin hydrochloride and other pharmaceutical products and medical supplies. The $1,249.50 ceiling value contract has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,018.25 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,788,625 units of Moxifloxacin HCL 400 mg tablets and has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of MOXIFLOXACIN HYDROCHL pharmaceuticals and related medical supplies. The $7,732.39 award has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for $1,334.77 to provide MOXIFLOXACIN HYDROCHL pharmaceutical products. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide moxifloxacin hydrochloride and other pharmaceutical products and medical supplies. The contract has a potential value of $6,487.35 and a completion date of February 1, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $6,623.50 contract is for the provision of MOXIFLOXACIN HYDROCHL pharmaceutical products to be delivered by February 1, 2024. This order is placed under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which...
- SPE2DX15D1902Indefinite Delivery Contract
- SPE2DX15D1902-SPE2DX24FC2CLDelivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,683.52 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide moxifloxacin hydrochloride and other pharmaceutical and medical supplies. The contract has a completion date of February 24, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide in support of the Department of Defense. This award does not utilize a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($118) | 2/24/24 | |
| Not listed | Not listed | $7.8k | 12/22/23 |